Sesen Bio
(NASDAQ) SESN
Sesen Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$10.63M
Net Income (TTM)
$31.12M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SESN News
Why Sesen Bio Stock Crashed Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sesen Bio
Industry
Biotechnology
Sector
Health CareEmployees
46
CEO
Steven Kelly, MBA
Website
www.carismatx.comHeadquarters
Cambridge, MA 02142, US
SESN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-10%
Net Income Margin
-3%
Return on Equity
-1%
Return on Capital
-432%
Return on Assets
5%
Earnings Yield
N/A
Dividend Yield
57.25%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$59.92M
Capital Expenditure
$123.00K
Free Cash Flow
$60.04M
Cash & ST Invst.
$17.91M
Total Debt
$2.48M
Sesen Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
17
N/A
Net Income
$44.72M
+452.0%
EBITDA
$44.72M
N/A
Quarterly Fundamentals
Net Cash
$2.02M
-91.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$609.00K
-28.9%
Short Term Debt
$153.00K
-93.8%
Return on Assets
4.75%
N/A
Return on Invested Capital
-431.82%
N/A
Free Cash Flow
$1.91M
+106.6%
Operating Cash Flow
$1.91M
+106.6%